TURNING POINT – “The panel recommends that bisphosphonates are considered as part of the adjuvant breast cancer treatment in postmenopausal women…”
P Hadji, R E. Coleman, C Wilson et al. (2016) Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel. Ann Oncol 2016, 27:379–90 Bisphosphonates should be considered as part [more]